Use of bromocriptine in Parkinson diseases in low doses at a slow rate. 40 patients
Liaño, H.; López-Lozano, J.J.; Ramírez, A.; Rabes, C.; Pascual, M.L.
Archivos de Neurobiologia 47(3): 143-150
1984
ISSN/ISBN: 0004-0576 PMID: 6508478 Document Number: 240122
Document emailed within 1 workday
Related Documents
Lieberman, A.N.; Kupersmith, M.; Neophytides, A.; Gopinathan, G.; Casson, I.; Durso, R.; Foo, S.H.; Khayali, M.; Tartaro, T.; Goldstein, M. 1980: Bromocriptine in Parkinson's disease: report on 106 patients treated for up to 5 years Advances in Biochemical Psychopharmacology 23: 245-253Potrebić, A.; Dragasević, N.; Svetel, M.; Kostić, V.S. 2001: Effect of slow repetitive transcranial magnetic stimulation on depression in patients with Parkinson disease Srpski Arhiv Za Celokupno Lekarstvo 129(1-2): 1-4
Mackenzie, R.A.; Lance, J.W. 1978: An evaluation of bromocriptine in the treatment of Parkinson's disease Clinical and Experimental Neurology 15: 228-236
Latkowski, B.; Zini, C.; Oppia, L.; Fois, L.; Sanna, M. 1975: Regularity of angular velocity rate of the slow rate of nystagmus in experimental and clinical lesions of the vestibular organ Otolaryngologia Polska 29(4): 321-328
Furgała, A.; Górecka-Mazur, A.; Fiszer, U.; Pietraszko, W.; Thor, P.; Moskała, M.; Potasz, K.; Bukowczan, M.; Polak, Jław.; Krygowska-Wajs, A. 2015: Evaluation of heart rate and blood pressure variability in Parkinson's disease patients after bilateral subthalamic deep brain stimulation Przeglad Lekarski 72(5): 246-252
Dormidontov, E.N.; Korshunov, N.I.; Baranova, E.I.; Zheltkevich, S.N.; Razumova, E.B. 1985: Use of high doses of glucocorticoids in patients with rheumatic diseases Terapevticheskii Arkhiv 57(8): 12-16
Peters, F. 1984: Use of bromocriptine in diseases of the breast Akusherstvo i Ginekologiia 5: 20-22
Losonczy, H.; Nagy, I.; Dávid, M. 1988: Effects of various doses of SP 54 on fibrinolytic activity in patients with thrombotic diseases Folia Haematologica 115(3): 388-393
Buvat, J.; Buvat-Herbaut, M. 1982: Prolactin, bromocriptine and gonadal function in women: recent advances. II. Treatment of female hyperprolactinemia and other indications for the use of bromocriptine Journal de Gynecologie Obstetrique et Biologie de la Reproduction 11(4): 509-521
Goh, P.P.; Teo, W.S. 1994: A man with dilated cardiomyopathy and a slow heart rate Singapore Medical Journal 35(3): 312
Felt, V.; Vána, S.; Nĕmec, J.; Silink, K. 1970: Comparison of larger and smaller doses of radioactive I-131 in the treatment of patients with heart diseases and thyrotoxicosis Casopis Lekaru Ceskych 109(9): 189-195
2003: Managed care outlook. HMO premium rate hikes slow a bit Managed Care 12(8): 48
Przybylski, A. 2009: Interruption of slow ventricular tachycardia below the detection rate of implantable cardioverter-defibrillators Kardiologia Polska 67(11): 1296
Torokhtin, M.D.; Zadorozhnaia, T.A.; Torokhtin, A.M.; Sarkanich, A.V.; Gabor, M.L. 1991: The effect of balneotherapy on the gastrointestinal hormone level of patients with digestive organ diseases subjected to small doses of radiation exposure Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 6: 18-21
Hayashi, H.; Honda, T.; Kawana, M.; Nimi, M. 1986: Improvement of the survival rate of patients with coronary diseases by the MCCU Nihon Rinsho. Japanese Journal of Clinical Medicine 44(6): 1279-1284
Eldridge, R.; Ince, S.E. 1984: The low concordance rate for Parkinson's disease in twins: a possible explanation Neurology 34(10): 1354-1356
Vidon, N.; Muschart, J.M.; Cosnes, J.; Ruskone, A.; Bernier, J.J. 1979: A critical study of gastric emptying by the dilution of a non-absorbable substance perfused in the duodenum at a slow flow rate Gastroenterologie Clinique et Biologique 3(6-7): 549-552
Neumann, H.H. 1977: Slow virus diseases Connecticut Medicine 41(12): 756-758
Savchenko, R.P. 1988: Study of body reactivity using the modified fractional rate of erythrocyte sedimentation in patients with kidney diseases Laboratornoe Delo 1: 19-21
Looney, W.B.; Ritenour, E.R.; Hopkins, H.A. 1980: Changes in growth rate of an experimental solid tumor following increasing doses of cyclophosphamide Cancer Research 40(7): 2179-2183